Porphyria-Safe Emergency Management in COVID-Associated GBS-Like Neuropathy: Why Early Medication Review Should Accompany PBG/ALA Testing.

In COVID-associated acute neuropathy with abdominal pain, seizures, hyponatremia, hypertension, or hepatic involvement, suspected acute intermittent porphyria should prompt both early PBG/ALA testing and immediate porphyria-safe medication review to avoid worsening neurovisceral attacks before diagnostic confirmation.